Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBLG | AMGN | VRTX | GILD | BMY |
| Company | Bone Biologics Corp | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.2700 | 319.59 | 503.00 | 96.35 | 59.82 |
| High | 1.3472 | 321.22 | 508.04 | 96.84 | 60.62 |
| Low | 1.2000 | 298.00 | 494.13 | 95.02 | 58.81 |
| Last | 1.2475 | 303.16 | 494.90 | 95.05 | 59.47 |
| Change | -0.0725 | -18.65 | -6.82 | -1.98 | -0.35 |
| % Change | -5.49% | -5.80% | -1.36% | -2.04% | -0.59% |
| Volume | 76,024 | 2,076,477 | 416,899 | 3,493,641 | 8,536,388 |
| 20-Day Average Volume | 325,876 | 1,844,086 | 1,102,119 | 6,079,602 | 10,128,732 |
| Previous Close | 1.3200 | 321.81 | 501.72 | 97.03 | 59.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5495 | 318.83 | 484.69 | 90.12 | 54.26 |
| 20-Day Raw Stochastic | 4.55% | 12.63% | 58.06% | 73.31% | 82.20% |
| 20-Day Relative Strength | 42.23% | 42.44% | 55.57% | 70.26% | 67.88% |
| Weighted Alpha | -88.64 | +13.78 | +36.37 | +37.62 | +27.80 |
| Today's Opinion | 72% Sell | 24% Sell | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 72% Sell | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 32% Sell | 56% Buy | 48% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.07% since 11/05/24 | -2.02% since 11/05/24 | -0.76% since 11/05/24 | +5.69% since 11/05/24 | +6.22% since 11/05/24 |
| Low | 1.2000 on 11/12/24 | 312.70 on 11/12/24 | 485.29 on 11/06/24 | 90.50 on 11/06/24 | 53.97 on 11/08/24 |
| High | 1.3960 on 11/06/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 1-Month | |||||
| %Chg | -25.15% since 10/11/24 | -4.72% since 10/11/24 | +2.98% since 10/11/24 | +12.24% since 10/11/24 | +13.85% since 10/11/24 |
| Low | 1.2000 on 11/12/24 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 84.34 on 10/14/24 | 51.31 on 10/15/24 |
| High | 2.3000 on 10/18/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 3-Month | |||||
| %Chg | -22.84% since 08/12/24 | -2.23% since 08/12/24 | +6.80% since 08/12/24 | +30.63% since 08/12/24 | +26.29% since 08/12/24 |
| Low | 0.8000 on 09/13/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 72.67 on 08/13/24 | 46.88 on 08/22/24 |
| High | 2.7500 on 09/25/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | -34.90% since 05/10/24 | +0.87% since 05/10/24 | +17.34% since 05/10/24 | +44.56% since 05/10/24 | +32.24% since 05/10/24 |
| Low | 0.8000 on 09/13/24 | 295.30 on 06/13/24 | 422.44 on 05/14/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 4.2500 on 07/24/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,378 | 172,983,504 | 129,207,448 | 120,801,568 | 121,325,552 |
| Shares Outstanding, K | 1,801 | 537,533 | 257,529 | 1,244,992 | 2,028,177 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -8,950,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -780,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 0.45 | 0.60 | 0.39 | 0.17 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.67 on 08/09/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 12/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.92 | 0.00 | 21.80 | 46.27 |